期刊
JOURNAL FOR SPECIALISTS IN PEDIATRIC NURSING
卷 14, 期 3, 页码 183-191出版社
WILEY
DOI: 10.1111/j.1744-6155.2009.00196.x
关键词
Antidepressants; autism; pervasive developmental disorder; pharmacotherapy; psychopharmacotherapy; selective serotonin reuptake inhibitors
PURPOSE. To review the potential role of serotonin dysregulation in autism and the efficacy of selective serotonin reuptake inhibitors (SSRIs) in treating core deficits and associated symptoms of autism in children. The literature was searched for reports of SSRI use in children with autism. Data are presented from prospective clinical trials that evaluated treatment outcomes. CONCLUSIONS. Some SSRIs show moderate success in managing specific behaviors. Only fluoxetine shows evidence of decreasing global autism severity. PRACTICE IMPLICATION. Definitive conclusions concerning selection criteria, dosage, safety, and efficacy cannot be drawn given the current state of evidence.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据